Martin T. Rothman

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Astron Clinica Ltd. designs, develops, and markets skin imaging and consultation systems. Its products are used to examine conditions such as acne, psoriasis and skin cancer. The firm's products are also used for wound management, plastic surgery, and the development of pharmaceutical & other products for the skin. Astron Clinica has developed a unique product suite that enables doctors and skincare specialists to look beneath the surface of the skin. Its patented technology, examine the main components of the skin hemoglobin, melanin, dermal melanin & collagen and provide a detailed set of images that add up to a powerful tool in diagnosis and monitoring.

Lombard Medical Technologies Ltd. was a medical technology company, which specialized in research and development, design, manufacture and commercialization of endovascular solutions. The company was founded in July 2000 and wass headquartered in London, the United Kingdom.

Lombard Medical Plc Discovered and developed cardiovascular devices. Its products include Aorfix and Anson Refix. The company was headquartered in Didcot, the United Kingdom.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

Barts & The London NHS Trust provides health care services in hospitals. Its services include air ambulance, hepatology, anaesthetics and pain management, haematology, paediatric respiratory, emergency department, endocrinology, Urology, and many more. The company is headquartered in Aldgate, the United Kingdom.